Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Intangibles: 2022-2025

Historic Change in Intangibles for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $15,000.

  • Gyre Therapeutics' Change in Intangibles was N/A to $15,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $813,000 for FY2024, which is 1078.26% up from last year.
  • Gyre Therapeutics' Change in Intangibles amounted to $15,000 in Q3 2025, which was down 34.78% from $23,000 recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Change in Intangibles high stood at $810,000 for Q4 2024, and its period low was -$55.0 million during Q4 2022.
  • Its 3-year average for Change in Intangibles is $202,000, with a median of $19,000 in 2025.
  • Data for Gyre Therapeutics' Change in Intangibles shows a peak YoY spiked of 80,900.00% (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Gyre Therapeutics' Change in Intangibles stood at -$55.0 million in 2022, then skyrocketed by 100.00% to $1,000 in 2023, then surged by 80,900.00% to $810,000 in 2024, then reached $15,000 in 2025.
  • Its Change in Intangibles was $15,000 in Q3 2025, compared to $23,000 in Q2 2025 and $699,000 in Q1 2025.